FDA recall D-0477-2023
Direct Rx · Class II · drug
Product
Finasteride, USP, 5 mg Tablets, Rx Only, Packaged as a 90-count bottle, NDC 61919-0733-90; Packaged and Distributed By: Direct Rx
Reason for recall
cGMP deviations
Distribution
Nationwide in the USA
Key facts
- Status
- Terminated
- Initiation date
- 2023-03-13
- Report date
- 2023-04-05
- Termination date
- 2024-06-17
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Dawsonville, GA, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0477-2023